Evidence map›Paper›PMID 19124761›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.

Jonathan Dodd, Sabine Riffault, Jayanie S Kodituwakku, Adrian C Hayday, Peter J M Openshaw

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 65 citations in OpenAlex.

  1. Pulmonary Immune Cell Landscape Altered by Exposure to HIV,International journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. γδT Cells Are Required for CD8Frontiers in immunology · 2021
    Article
  9. Review
  10. Review
  11. β2 Integrins differentially regulate γδ T cell subset thymic development and peripheral maintenance.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jonathan DoddCenter for Respiratory Infections, National Heart and Lung Institute, St. Mary's Campus, Imperial College London, UK.
Sabine Riffault
Jayanie S Kodituwakku
Adrian C Hayday
Peter J M Openshaw
Lung Institute · USVirologie et Immunologie Moléculaires · FRGuy's Hospital · GB

Funding

Wellcome Trust 071381Wellcome Trust 071534
6 · The paper itself

Abstract

Host defenses, while effecting viral clearance, contribute substantially to inflammation and disease. This double action is a substantial obstacle to the development of safe and effective vaccines against many agents, particularly respiratory syncytial virus (RSV). RSV is a common cold virus and the major cause of infantile bronchiolitis worldwide. The role of alphabeta T cells in RSV-driven immunopathology is well studied, but little is known about the role of "unconventional" T cells. During primary RSV challenge of BALB/c mice, some Vgamma7+ gammadelta T cells were present; however, immunization with a live vaccinia vector expressing RSV F protein substantially enhanced Vgamma4+ gammadelta T cell influx after RSV infection. Harvested early, these cells produced IFN-gamma, TNF, and RANTES after ex vivo stimulation. By contrast, those recruited 5 days after challenge made IL-4, IL-5, and IL-10. Depletion of gammadelta T cells in vivo reduced lung inflammation and disease severity and slightly increased peak viral replication but did not prevent viral clearance. These studies demonstrate a novel role for gammadelta T cells in the development of immunopathology and cellular influx into the lungs after immunization and RSV challenge. Though a minor population, gammadelta T cells have a critical influence on disease and are an attractive interventional target in the alleviation of viral lung disease.

Indexed as

Adjuvants, ImmunologicAnimalsCell MovementFemaleInflammation MediatorsLungLymphocyte ActivationLymphocyte DepletionMiceMice, Inbred BALB CReceptors, Antigen, T-Cell, gamma-deltaRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesSeverity of Illness IndexT-Lymphocyte SubsetsAdjuvants, ImmunologicInflammation MediatorsReceptors, Antigen, T-Cell, gamma-deltaRespiratory Syncytial Virus VaccinesVaccines, SyntheticViral Fusion Proteins

Identifiers

PMID19124761
PMCPMC2646375
OpenAlexW1479692645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.